Surgical Robots in China
Surgical robot systems operating in the Chinese market, spanning laparoscopic, vascular interventional, neurosurgical, orthopedic, and single-port platforms. NMPA regulatory …
explore ›Surgical robot systems operating in the Chinese market, spanning laparoscopic, vascular interventional, neurosurgical, orthopedic, and single-port platforms. NMPA regulatory …
explore ›Rehabilitation robotics in China covering exoskeletons, upper- and lower-limb training systems, hand and gait rehabilitation, and neurorehabilitation platforms. Clinical …
explore ›Medical and consumer exoskeletons in the Chinese market — lower-limb and upper-limb systems, lumbar support devices, and whole-body platforms. Products from Hypershell, BESKAR, …
explore ›Delivery, guidance, and service robots for Chinese hospitals — inpatient material transport, reception and wayfinding, nuclear medicine handling, and outpatient guidance. Products …
explore ›Endoscopic and bronchoscopic robot systems in the Chinese market, including flexible endoscopy platforms, capsule endoscopy, and robotic bronchoscopy navigation. NMPA status and …
explore ›Hospital pharmacy automation in China — tablet dispensing systems, IV compounding robots (PIVAS), medication cabinets, and outpatient pharmacy workflows. NMPA status and …
explore ›Vascular interventional robotics for PCI, peripheral, and neurovascular procedures operating in China. Systems from Hanglok, MicroPort, Robocath, Aopeng, and others. NMPA approval …
explore ›Autonomous disinfection robots for hospitals and public spaces in China — UV, hydrogen peroxide vapor, plasma, and combined systems. Products from Boocax, Reeman, Smart-Sala, …
explore ›Laboratory automation, in-vitro diagnostics (IVD), and life-sciences robotics in the Chinese market — liquid handling, sample processing, immunoassay systems, microbiology, …
explore ›Dental implant navigation and robotic surgery systems operating in the Chinese market. Products from Yakebot, Remebot, DenCore, Theta, Shuzhidao, and others, with NMPA status and …
explore ›